98.92
price up icon0.65%   0.64
after-market アフターアワーズ: 98.62 -0.30 -0.30%
loading
前日終値:
$98.28
開ける:
$99.41
24時間の取引高:
8.28M
Relative Volume:
0.79
時価総額:
$251.88B
収益:
$63.17B
当期純損益:
$12.15B
株価収益率:
20.74
EPS:
4.77
ネットキャッシュフロー:
$14.84B
1週間 パフォーマンス:
+2.37%
1か月 パフォーマンス:
+0.56%
6か月 パフォーマンス:
-14.17%
1年 パフォーマンス:
-18.69%
1日の値動き範囲:
Value
$98.23
$99.41
1週間の範囲:
Value
$95.41
$99.41
52週間の値動き範囲:
Value
$94.48
$134.63

Merck Co Inc Stock (MRK) Company Profile

Name
名前
Merck Co Inc
Name
セクター
Healthcare (1179)
Name
電話
908-740-4000
Name
住所
2000 GALLOPING HILL ROAD, KENILWORTH, NJ
Name
職員
0
Name
Twitter
@Merck
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
MRK's Discussions on Twitter

MRK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
MRK
Merck Co Inc
98.92 251.88B 63.17B 12.15B 14.84B 4.77
Drug Manufacturers - General icon
LLY
Lilly Eli Co
823.23 778.66B 40.86B 8.37B -2.28B 9.25
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
85.34 379.90B 39.36B 13.79B 9.83B 3.086
Drug Manufacturers - General icon
JNJ
Johnson Johnson
152.87 344.63B 88.82B 14.07B 19.03B 5.79
Drug Manufacturers - General icon
ABBV
Abbvie Inc
175.59 310.55B 55.53B 5.12B 15.62B 2.88

Merck Co Inc Stock (MRK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-01-08 ダウングレード Truist Buy → Hold
2024-12-20 ダウングレード BMO Capital Markets Outperform → Market Perform
2024-12-10 再開されました BofA Securities Buy
2024-12-04 アップグレード HSBC Securities Hold → Buy
2024-11-15 開始されました Wolfe Research Peer Perform
2024-11-11 ダウングレード Daiwa Securities Buy → Neutral
2024-10-17 開始されました Bernstein Mkt Perform
2024-03-11 ダウングレード Societe Generale Hold → Sell
2024-01-04 アップグレード TD Cowen Market Perform → Outperform
2023-11-09 開始されました Deutsche Bank Buy
2023-10-27 アップグレード BMO Capital Markets Market Perform → Outperform
2023-10-20 アップグレード UBS Neutral → Buy
2023-07-14 開始されました HSBC Securities Hold
2023-04-13 アップグレード Citigroup Neutral → Buy
2023-03-28 ダウングレード Societe Generale Buy → Hold
2023-03-13 ダウングレード Wells Fargo Overweight → Equal Weight
2023-03-06 開始されました Jefferies Buy
2023-02-22 アップグレード Wolfe Research Peer Perform → Outperform
2023-01-04 アップグレード BofA Securities Neutral → Buy
2022-11-18 開始されました Credit Suisse Outperform
2022-10-10 アップグレード Guggenheim Neutral → Buy
2022-09-14 アップグレード Berenberg Hold → Buy
2022-07-06 アップグレード Daiwa Securities Neutral → Buy
2022-06-06 再開されました SVB Leerink Outperform
2022-04-06 再開されました Morgan Stanley Equal-Weight
2021-12-17 開始されました Goldman Buy
2021-12-16 開始されました Daiwa Securities Neutral
2021-12-13 ダウングレード UBS Buy → Neutral
2021-12-09 開始されました Wells Fargo Overweight
2021-12-07 ダウングレード Guggenheim Buy → Neutral
2021-11-29 ダウングレード Citigroup Buy → Neutral
2021-11-19 開始されました BMO Capital Markets Market Perform
2021-11-01 アップグレード Argus Hold → Buy
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-07-27 再開されました Truist Buy
2021-05-20 ダウングレード Argus Buy → Hold
2021-04-07 再開されました RBC Capital Mkts Sector Perform
2020-11-10 再開されました Bernstein Outperform
2020-09-29 開始されました Berenberg Hold
2020-08-03 アップグレード Goldman Neutral → Buy
2020-06-12 ダウングレード Wolfe Research Outperform → Peer Perform
2020-02-27 開始されました Barclays Overweight
2020-01-07 開始されました RBC Capital Mkts Sector Perform
2019-10-17 再開されました BofA/Merrill Neutral
2019-08-16 開始されました SVB Leerink Outperform
2019-07-03 開始されました Mizuho Buy
2019-05-28 開始されました Goldman Neutral
2019-05-13 アップグレード Atlantic Equities Neutral → Overweight
2018-10-16 繰り返されました Citigroup Buy
2018-10-09 再開されました Guggenheim Buy
2018-04-23 アップグレード Goldman Neutral → Buy
2018-04-17 アップグレード Morgan Stanley Equal-Weight → Overweight
2018-04-05 アップグレード Barclays Equal Weight → Overweight
2018-03-12 アップグレード Leerink Partners Mkt Perform → Outperform
2018-02-14 繰り返されました Leerink Partners Mkt Perform
2018-02-07 繰り返されました Morgan Stanley Equal-Weight
2018-01-16 アップグレード SunTrust Hold → Buy
すべてを表示

Merck Co Inc (MRK) 最新ニュース

pulisher
12:48 PM

Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things - Insider Monkey

12:48 PM
pulisher
10:01 AM

Noteworthy Insider Activity: Chirfi Guindo Invests $2.76M In Merck & Co Stock - Benzinga

10:01 AM
pulisher
10:01 AM

Chairman Of Merck & Co Makes $9.33M Buy - Benzinga

10:01 AM
pulisher
10:01 AM

EVP & CFO Of Merck & Co Makes $2.29M Buy - Benzinga

10:01 AM
pulisher
10:01 AM

Johannes Oosthuizen's Recent Buy: Acquires $848K In Merck & Co Stock - Benzinga

10:01 AM
pulisher
10:01 AM

Major Purchase Alert: Jennifer Zachary Invests $2.49M In Merck & Co Stock - Benzinga

10:01 AM
pulisher
09:47 AM

Crews Bank & Trust Invests $900,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

09:47 AM
pulisher
09:15 AM

Up More Than 500% in 12 Months, Is It Too Late to Buy Summit Therapeutics Stock? - The Motley Fool

09:15 AM
pulisher
09:05 AM

OLD National Bancorp IN Sells 3,371 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

09:05 AM
pulisher
09:00 AM

Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

09:00 AM
pulisher
08:48 AM

Merck & Co., Inc. (NYSE:MRK) Shares Sold by BDF Gestion - MarketBeat

08:48 AM
pulisher
08:40 AM

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Sentry LLC - MarketBeat

08:40 AM
pulisher
08:16 AM

Merck: Phase III study on Winrevair halted -January 30, 2025 at 08:16 am EST - Marketscreener.com

08:16 AM
pulisher
08:04 AM

Merck & Co., Inc. (NYSE:MRK) Stock Position Raised by Synergy Asset Management LLC - MarketBeat

08:04 AM
pulisher
07:57 AM

Merck Stops Late-Stage Trial of Winrevair Early, Moves to Final Analysis -January 30, 2025 at 07:57 am EST - Marketscreener.com

07:57 AM
pulisher
07:39 AM

Highland Capital Management LLC Has $30.26 Million Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

07:39 AM
pulisher
07:19 AM

Summa Corp. Invests $506,000 in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

07:19 AM
pulisher
06:50 AM

Manning & Napier Advisors LLC Invests $7.42 Million in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

06:50 AM
pulisher
06:48 AM

Merck to stop lung condition drug study early due to strong efficacy data - Reuters

06:48 AM
pulisher
Jan 29, 2025

Merck's SWOT analysis: pharma giant's stock faces China setback, PAH potential - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

Is Merck & Co., Inc. (MRK) Among the Best Blue Chip Stocks to Buy Under $100? - Insider Monkey

Jan 29, 2025
pulisher
Jan 29, 2025

A Closer Look at Merck & Co's Options Market Dynamics - Benzinga

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Orrstown Financial Services Inc. - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Swedbank AB Purchases 130,541 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Strategic Blueprint LLC - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Asset Dedication LLC Sells 15,418 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Robeco Institutional Asset Management B.V. Trims Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Sumitomo Life Insurance Co. Reduces Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Twelve Points Wealth Management LLC Increases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc.'s (NYSE:MRK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc. (MRK): Is This Healthcare Stock A Good Buy? - Insider Monkey

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc. (NYSE:MRK) Shares Sold by SteelPeak Wealth LLC - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Merck & Co., Inc. (NYSE:MRK) Shares Sold by Capital Investment Counsel LLC - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Orca Wealth Management LLC Makes New Investment in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Nilsine Partners LLC Has $1.19 Million Stock Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 29, 2025
pulisher
Jan 29, 2025

Hodgkin Lymphoma Market Promising Growth Anticipated by 2031 | Merck & Co., Inc., Bristol Myers Squibb, Seagen Inc. - openPR

Jan 29, 2025
pulisher
Jan 28, 2025

Share Buyback Program Announced by Merck & Co., Inc. (NYSE:MRK) Board of Directors - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Merck & Co., Inc. (NYSE:MRK) Plans $0.81 Quarterly Dividend - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Merck announces $0.81 dividend and $10 billion buyback - MSN

Jan 28, 2025
pulisher
Jan 28, 2025

Merck Announces $10 Billion Share Repurchase Authorization -January 28, 2025 at 02:01 pm EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Merck's Board Authorizes Additional $10 Billion Stock Buyback Plan -January 28, 2025 at 01:39 pm EST - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Merck Authorizes $10 Billion Share Repurchase, Maintains Quarterly Dividend at $0.81 a Share - Marketscreener.com

Jan 28, 2025
pulisher
Jan 28, 2025

Merck stock in focus after share buybacks (MRK:NYSE) - Seeking Alpha

Jan 28, 2025
pulisher
Jan 28, 2025

Merck Announces Second-Quarter 2025 Dividend and $10 Billion Share Repurchase Authorization - Business Wire

Jan 28, 2025
pulisher
Jan 28, 2025

Is Merck & Co. (MRK) Among Kevin O’Leary’s Stock Picks for 2025? - Yahoo Finance

Jan 28, 2025
pulisher
Jan 28, 2025

Perigon Wealth Management LLC Sells 4,971 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Griffin Asset Management Inc. Sells 2,868 Shares of Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Sterling Investment Counsel LLC Trims Holdings in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Forecasting The Future: 12 Analyst Projections For Merck & Co - Benzinga

Jan 28, 2025
pulisher
Jan 28, 2025

Merck & Co., Inc. (NYSE:MRK) is Town & Country Bank & Trust CO dba First Bankers Trust CO's 7th Largest Position - MarketBeat

Jan 28, 2025
pulisher
Jan 28, 2025

Buffington Mohr McNeal Decreases Stock Position in Merck & Co., Inc. (NYSE:MRK) - MarketBeat

Jan 28, 2025

Merck Co Inc (MRK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general NVS
$104.77
price up icon 1.79%
$175.59
price up icon 0.19%
drug_manufacturers_general JNJ
$152.87
price up icon 1.14%
$284.02
price up icon 0.85%
drug_manufacturers_general PFE
$26.91
price up icon 1.09%
大文字化:     |  ボリューム (24 時間):